Early research (Phase 1)Study completedNCT04765436
What this trial is testing
PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64
Who this might be right for
Covid19 Vaccine
Providence Therapeutics Holdings Inc. 60